萬盛股份(603010.SH)收到法院撤訴裁定書
格隆匯1月12日丨萬盛股份(603010.SH)公佈,公司因與嘉興海大數模投資合夥企業(有限合夥)(以下簡稱“海大數模”)股權轉讓糾紛一事,於2020年12月14日向浙江省台州市中級人民法院遞交了《民事起訴狀》,並於同日收到浙江省台州市中級人民法院出具的《立案申請吿知書》。
2021年1月12日,公司收到浙江省台州市中級人民法院送達的《民事裁定書》(2020)浙10民初613號,台州市中級人民法院認為原吿提出的撤訴申請符合法律規定,依照《中華人民共和國民事訴訟法》第一百四十五條第一款規定,裁定如下:准許原吿浙江萬盛股份有限公司撤訴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.